ImmunityBio, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ImmunityBio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • ImmunityBio, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$35.3M, a 33.6% increase year-over-year.
  • ImmunityBio, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$238M, a 134% decline year-over-year.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2023 was -$222M, a 236% decline from 2022.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2022 was -$66M, a 237% decline from 2021.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2021 was -$19.6M, a 280% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$222M -$156M -236% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$66M -$46.4M -237% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$19.6M -$14.4M -280% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 -$5.15M -$1.14M -28.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4.01M -$5.67M -342% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.66M -$544K -24.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $2.2M -$915K -29.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-25
2016 $3.12M +$1.42M +83.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $1.7M +$2.31M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$609K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.